Equities

Sunwels Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
9229:TYO

Sunwels Co Ltd

Actions
Health CareHealth Care Providers
  • Price (JPY)306.00
  • Today's Change-22.00 / -6.71%
  • Shares traded373.00k
  • 1 Year change-44.86%
  • Beta0.8648
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sunwels Co Ltd is a Japan-based company primarily engaged in the operation of nursing care facilities. The Nursing Care business segment is primarily engaged in the provision of nursing care services through the operation of nursing care facilities. The main services include the provision of specialized Parkinson's disease homes for Parkinson's disease patients, specialized medical care homes for patients with cancer and other intractable diseases, people certified as requiring long-term care, and dementia patients, as well as dementia-compatible communal living care, day care, home nursing/care prevention home care, home care/comprehensive services for care prevention and daily living support, in-home care support, and in-home care/severe visiting care. The Company is also engaged in the operation of welfare equipment rental and sales business, home remodeling business, and Kaatsu training gym business.

  • Revenue in JPY (TTM)26.82bn
  • Net income in JPY-2.68bn
  • Incorporated2006
  • Employees3.30k
  • Location
    Sunwels Co Ltd15-13, Ninomiya-machiKANAZAWA-SHI 920-0067JapanJPN
  • Phone+81 762728982
  • Fax+81 762728986
  • Websitehttps://sunwels.jp/pdh/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shigematsu Works Co Ltd14.86bn699.28m5.88bn390.008.310.64663.720.395798.3398.332,090.311,263.520.75782.033.5738,115,200.003.564.495.777.1430.4831.444.705.190.870240.230.410313.798.604.0033.6424.0329.828.45
Care Twentyone Corp48.16bn384.17m6.55bn6.32k15.511.353.580.135928.4328.433,566.14327.361.54783.717.647,621,168.001.431.352.351.9523.0922.820.92951.111.0520.400.80550.046.087.2237.98-11.42-15.957.82
As Partners Co Ltd20.94bn1.14bn8.79bn879.007.741.736.760.4195316.94316.945,800.971,416.391.075.839.5523,822,800.005.83--11.48--19.38--5.47--0.919418.210.596--4.47--69.75------
Uchiyama Holdings Co Ltd29.44bn2.13bn8.80bn2.27k3.700.54073.340.2989110.11110.111,518.29752.780.966957.4310.8512,979,990.007.01-0.66969.43-0.92337.024.727.25-0.7612.2112.460.4452--0.9117-0.7977858.92278.17-8.230.00
StemCell Institute Inc2.72bn198.73m8.81bn117.0044.103.3226.163.2419.5019.50266.94259.060.367920.681.4323,251,740.002.694.036.519.9961.8363.587.3110.451.21--0.135923.487.989.8324.066.8154.63--
Japan Hospice Holdings Inc13.60bn506.31m9.06bn1.09k17.852.458.340.666160.2160.211,614.46439.580.7687--6.6212,433,290.002.864.013.424.7714.6518.613.725.26--2.290.76875.8422.7323.64-6.2016.51109.92--
Advantage Risk Management Co., Ltd.9.75bn1.06bn10.00bn519.009.222.354.921.0266.6266.62615.70260.891.10--8.0618,792,050.0011.917.4718.8911.5467.3372.1910.837.00--314.470.312241.6922.2310.2047.233.0925.717.78
Sunwels Co Ltd26.82bn-2.68bn11.55bn3.30k--1.50--0.4308-82.76-82.76826.87219.070.62841,764.005.868,121,139.00-6.292.79-7.413.5911.1924.62-10.013.171.27-1.140.803538.5924.0443.33-145.52--51.83--
Wellness Communications Corp14.52bn832.91m12.28bn122.0014.382.2711.190.845768.4968.491,213.83434.041.8334.975.39118,992,300.0010.51--19.49--20.05--5.74--2.04--0.00--5.96--14.08------
WOLVES HAND Co Ltd5.58bn691.08m16.23bn453.0022.905.2820.442.9188.8588.85720.79385.660.947245.0125.42--11.74--15.82--27.64--12.39--0.66936.230.456--9.48--6.20------
Data as of Feb 13 2026. Currency figures normalised to Sunwels Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

12.97%Per cent of shares held by top holders
HolderShares% Held
FIL Investments (Japan) Ltd.as of 15 Oct 20242.23m6.32%
Asset Management One Co., Ltd.as of 13 Sep 20241.10m3.13%
Nomura Asset Management Co., Ltd.as of 08 Jan 2026481.00k1.37%
Amova Asset Management Co., Ltd.as of 09 Jan 2026224.70k0.64%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2025216.40k0.61%
SSgA Funds Management, Inc.as of 08 Jan 2026129.90k0.37%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 202689.70k0.26%
Chibagin Asset Management Co. Ltd.as of 30 May 202447.20k0.13%
American Century Investment Management, Inc.as of 08 Jan 202630.70k0.09%
BlackRock Japan Co. Ltd.as of 08 Jan 202618.20k0.05%
More ▼
Data from 22 Jul 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.